Cellectar Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $309 |
Gross Profit | -52 | -56 | 154 | |
EBITDA | -4,391 | -5,981 | -6,344 | -12,676 |
EBIT | -4,443 | -6,037 | -6,400 | -12,744 |
Net Income | -4,443 | -5,447 | -6,604 | -2,355 |
Net Change In Cash | 0 | 0 | 0 | 309 |
Free Cash Flow | -4,275 | -5,115 | -9,383 | -10,974 |
Cash | 12,554 | 11,041 | 13,905 | 23,288 |
Basic Shares | 3,162 | 1,608 | 1,535 | 1,397 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -291 | -192 | -238 | -227 |
EBITDA | -51,486 | -38,768 | -28,665 | -23,981 |
EBIT | -51,777 | -38,960 | -28,813 | -24,131 |
Net Income | -44,581 | -42,770 | -28,601 | -23,970 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -47,687 | -33,241 | -25,448 | -22,710 |
Cash | 23,288 | 9,564 | 19,866 | 35,703 |
Basic Shares | 1,238 | 407 | 235 | 185 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$1.41 |
2025-06-30 | -$3.39 |
2025-03-31 | -$0.14 |
2024-12-31 | -$0.01 |
